BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27198988)

  • 1. In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by Its Active Flavonoids in Breast Cancer Cells.
    Noolu B; Gogulothu R; Bhat M; Qadri SS; Reddy VS; Reddy GB; Ismail A
    Anticancer Agents Med Chem; 2016; 16(12):1605-1614. PubMed ID: 27198988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murraya koenigii leaf extract inhibits proteasome activity and induces cell death in breast cancer cells.
    Noolu B; Ajumeera R; Chauhan A; Nagalla B; Manchala R; Ismail A
    BMC Complement Altern Med; 2013 Jan; 13():7. PubMed ID: 23302496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity and Proteasome Inhibition by Alkaloid Extract from Murraya koenigii Leaves in Breast Cancer Cells-Molecular Docking Studies.
    Ismail A; Noolu B; Gogulothu R; Perugu S; Rajanna A; Babu SK
    J Med Food; 2016 Dec; 19(12):1155-1165. PubMed ID: 27982755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive potential of hydroethanolic Murraya koenigii leaves extract against DMBA induced breast carcinogenesis: In-silico and in-vivo study.
    Sadwal S; Bharati S; Dar ZA; Kaur S
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117124. PubMed ID: 37678421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic Flavonoids from the Leaves and Twigs of
    You CX; Zhang K; Li X; Liu J; Zhang WJ; Yu XX
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33652969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer and anti-inflammatory activities of girinimbine isolated from
    Iman V; Mohan S; Abdelwahab SI; Karimian H; Nordin N; Fadaeinasab M; Noordin MI; Noor SM
    Drug Des Devel Ther; 2017; 11():103-121. PubMed ID: 28096658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of proteasome activity by the dietary flavonoid apigenin is associated with growth inhibition in cultured breast cancer cells and xenografts.
    Chen D; Landis-Piwowar KR; Chen MS; Dou QP
    Breast Cancer Res; 2007; 9(6):R80. PubMed ID: 18300387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a novel dipeptidyl boronic acid proteasome inhibitor for the treatment of multiple myeloma and triple-negative breast cancer.
    Lei M; Feng H; Bai E; Zhou H; Wang J; Qin Y; Zhang H; Wang X; Liu Z; Hai O; Liu J; Zhu Y
    Org Biomol Chem; 2019 Jan; 17(3):683-691. PubMed ID: 30601533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of an Artemisia annua herbal preparation and identification of active ingredients.
    Lang SJ; Schmiech M; Hafner S; Paetz C; Steinborn C; Huber R; Gaafary ME; Werner K; Schmidt CQ; Syrovets T; Simmet T
    Phytomedicine; 2019 Sep; 62():152962. PubMed ID: 31132755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis.
    Arun A; Patel OPS; Saini D; Yadav PP; Konwar R
    Biomed Pharmacother; 2017 Sep; 93():510-521. PubMed ID: 28675857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of ultrasound-assisted extraction of flavonoid compounds and their pharmaceutical activity from curry leaf (Murraya koenigii L.) using response surface methodology.
    Ghasemzadeh A; Jaafar HZ; Karimi E; Rahmat A
    BMC Complement Altern Med; 2014 Aug; 14():318. PubMed ID: 25169626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of antibacterial and cytotoxic activity of Artemisia nilagirica and Murraya koenigii leaf extracts against mycobacteria and macrophages.
    Naik SK; Mohanty S; Padhi A; Pati R; Sonawane A
    BMC Complement Altern Med; 2014 Mar; 14():87. PubMed ID: 24597853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cytotoxic effect of Plantago lanceolata L. against breast cancer cells.
    Alsaraf KM; Mohammad MH; Al-Shammari AM; Abbas IS
    J Egypt Natl Canc Inst; 2019 Dec; 31(1):10. PubMed ID: 32372137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical composition of Solanum nigrum linn extract and induction of autophagy by leaf water extract and its major flavonoids in AU565 breast cancer cells.
    Huang HC; Syu KY; Lin JK
    J Agric Food Chem; 2010 Aug; 58(15):8699-708. PubMed ID: 20681660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and mechanism of flavonoids from Astragalus complanatus on breast cancer growth.
    Zhu J; Zhang H; Zhu Z; Zhang Q; Ma X; Cui Z; Yao T
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Sep; 388(9):965-72. PubMed ID: 25902740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
    Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
    Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procyanidin-B2 enriched fraction of cinnamon acts as a proteasome inhibitor and anti-proliferative agent in human prostate cancer cells.
    Gopalakrishnan S; Ediga HH; Reddy SS; Reddy GB; Ismail A
    IUBMB Life; 2018 May; 70(5):445-457. PubMed ID: 29537730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Hydroxy Groups in the A-Ring on the Anti-proteasome Activity of Flavone.
    Nakamura K; Yang JH; Sato E; Miura N; Wu YX
    Biol Pharm Bull; 2015; 38(6):935-40. PubMed ID: 25810454
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Karimian H; Arya A; Fadaeinasab M; Razavi M; Hajrezaei M; Karim Khan A; Mohd Ali H; Abdulla MA; Noordin MI
    Drug Des Devel Ther; 2017; 11():337-350. PubMed ID: 28203057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.